Philip Hempleman, Ardsley Partners Initiate Position in Supernus Pharmaceuticals Inc (SUPN)
Philip Hempleman has become a fan of Supernus Pharmaceuticals Inc (NASDAQ:SUPN).
Posts Tagged ‘Samuel Isaly OrbiMed Advisors’
Goldman Capital Management Reduces Stake in Bacterin International Holdings Inc (BONE)
Goldman Capital Management Inc has reduced its exposure to Bacterin International Holdings Inc (NYSEMKT:BONE).
Sam Isaly, Orbimed Now Hold 53.3% of Response Biomedical
Sam Isaly's Orbimed Advisors focuses on healthcare investments, and it has now disclosed a change to its holdings of Response Biomedical Corp.
The Biggest Biogen Idec Inc. (BIIB) Bulls Around
In the financial blogosphere, there are a lot of analytical tools for Biogen Idec Inc.
Pfizer Inc. (PFE), Gilead Sciences, Inc. (GILD), Merck & Co., Inc. (MRK) Among Hedge Funds’ Favorite Pharma Stocks
We maintain a database of quarterly 13F filings from hundreds of hedge funds and other notable investors.
Should You Buy Vocera Communications Inc (VCRA)?
Vocera Communications Inc (NYSE:VCRA) was in 14 hedge funds' portfolio at the end of the first quarter of 2013.
Is Given Imaging Ltd. (GIVN) Going to Burn These Hedge Funds?
Given Imaging Ltd. (NASDAQ:GIVN) was in 14 hedge funds' portfolio at the end of March. GIVN has seen an increase in enthusiasm from smart money lately.
Is Array Biopharma Inc (ARRY) Going to Burn These Hedge Funds?
If you'd ask most shareholders, hedge funds are seen as slow, old investment vehicles of the past.
Is Acorda Therapeutics Inc (ACOR) Going to Burn These Hedge Funds?
Acorda Therapeutics Inc (NASDAQ:ACOR) was in 10 hedge funds' portfolio at the end of March. ACOR has experienced a decrease in hedge fund sentiment lately.
Impax Laboratories Inc (IPXL): Insiders Are Buying, Should You?
In the financial world, there are plenty of metrics market participants can use to track publicly traded companies.
Regeneron Pharmaceuticals Inc (REGN): Are Hedge Funds Right About This Stock?
To the average investor, there are dozens of indicators market participants can use to analyze the equity markets.
Orbimed Advisors Takes a Major Stake in Ambit Biosciences Corp (AMBI)
In the smart money’s world, Samuel Isaly’s Orbimed Advisors reported a purchase of some 2.1 million shares of Ambit Biosciences Corp (NASDAQ:AMBI) in a 13D filing with the...
Hedge Funds Are Betting On Gilead Sciences, Inc. (GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) was in 63 hedge funds' portfolio at the end of March. GILD shareholders have witnessed an increase in hedge fund sentiment of late.
Here is What Hedge Funds Think About Infinity Pharmaceuticals Inc. (INFI)
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) was in 22 hedge funds' portfolio at the end of March.
Is Biogen Idec Inc. (BIIB) Going to Burn These Hedge Funds?
To most traders, hedge funds are assumed to be worthless, outdated financial tools of years past.
Amgen, Inc. (AMGN): Insiders Aren’t Crazy About It
Amgen, Inc. (NASDAQ:AMGN) was in 36 hedge funds' portfolio at the end of the first quarter of 2013.
Hedge Fund News: Warren Buffett, Steve Cohen, Sprint Nextel Corporation (S)
Editor's Note: Related Tickers: Baidu.com, Inc. (ADR) (NASDAQ:BIDU), Micron Technology, Inc.
Infinity Pharmaceuticals Inc. (INFI): Billionaire Steve Cohen’ SAC Up to 5% of This Stock
According to a 13G filed with the SEC, SAC Capital Advisors, a hedge fund managed by billionaire Steve Cohen, owned 2.4 million shares of Infinity Pharmaceuticals Inc.
Here is What Hedge Funds Think About Antares Pharma Inc (ATRS)
In the 21st century investor’s toolkit, there are a multitude of metrics shareholders can use to track the equity markets.
Hedge Funds Are Selling XOMA Corp (XOMA)
If you'd ask most investors, hedge funds are perceived as slow, outdated financial tools of the past.
This Metric Says You Are Smart to Sell Endocyte, Inc. (ECYT)
In the financial world, there are tons of indicators investors can use to monitor publicly traded companies. A couple of the best are hedge fund and insider trading interest.
Hedge Funds Aren’t Crazy About Fluidigm Corporation (FLDM) Anymore
Fluidigm Corporation (NASDAQ:FLDM) was in 7 hedge funds' portfolio at the end of the fourth quarter of 2012.
Hedge Funds Are Buying Uroplasty, Inc. (UPI)
Is Uroplasty, Inc. (NASDAQ:UPI) an excellent investment now? The smart money is taking an optimistic view.
Given Imaging Ltd. (GIVN): Hedge Funds and Insiders Are Bearish, What Should You Do?: Cynosure, Inc. (CYNO), Symmetry Medical Inc. (SMA)
Given Imaging Ltd. (NASDAQ:GIVN) was in 9 hedge funds' portfolio at the end of December.
Hedge Funds Are Dumping Dendreon Corporation (DNDN): Achillion Pharmaceuticals, Inc. (ACHN), TESARO Inc (TSRO)
If you'd ask most traders, hedge funds are perceived as underperforming, outdated investment tools of years past.
Medivation Inc (MDVN), Amarin Corporation plc (ADR) (AMRN), Abbott Laboratories (ABT): Adage Capital Management Owns 5.4% of This Company
According to a 13G filed with the SEC, Adage Capital Management, a large hedge fund managed by Phil Gross and Robert Atchinson, owns just over 4 million shares of Medivation Inc...
Hedge Funds Aren’t Crazy About MAKO Surgical Corp. (MAKO) Anymore: The Spectranetics Corporation (SPNC), Symmetry Medical Inc. (SMA)
MAKO Surgical Corp. (NASDAQ:MAKO) was in 13 hedge funds' portfolio at the end of December. MAKO investors should pay attention to a decrease in hedge fund interest lately.
XenoPort, Inc. (NASDAQ:XNPT): Insiders Are Dumping, Should You?: Obagi Medical Products, Inc. (OMPI), Vical Incorporated (VICL)
XenoPort, Inc. (NASDAQ:XNPT) was in 13 hedge funds' portfolio at the end of December.
Hedge Funds Aren’t Crazy About Neurocrine Biosciences, Inc. (NBIX) Anymore: Keryx Biopharmaceuticals (KERX), Rigel Pharmaceuticals, Inc. (RIGL)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was in 12 hedge funds' portfolio at the end of December.
Hedge Funds Are Betting On Natus Medical Inc (NASDAQ:BABY) – GenMark Diagnostics, Inc (NASDAQ:GNMK), Symmetry Medical Inc. (NYSE:SMA)
Natus Medical Inc (NASDAQ:BABY) was in 15 hedge funds' portfolio at the end of December. BABY investors should pay attention to an increase in hedge fund interest recently.
Should You Buy Impax Laboratories Inc (NASDAQ:IPXL)?
If you'd ask most shareholders, hedge funds are seen as slow, outdated financial vehicles of yesteryear.
Hedge Funds Are Crazy About Sequenom, Inc. (NASDAQ:SQNM)
Sequenom, Inc. (NASDAQ:SQNM) was in 15 hedge funds' portfolio at the end of December. SQNM shareholders have witnessed an increase in hedge fund sentiment lately.
Here is What Hedge Funds Think About OraSure Technologies, Inc. (NASDAQ:OSUR)
In the 21st century investor’s toolkit, there are a multitude of indicators shareholders can use to monitor the equity markets.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Are Hedge Funds Right About This Stock?
In the financial world, there are many methods shareholders can use to analyze the equity markets.
Do Hedge Funds and Insiders Love Warner Chilcott Plc (NASDAQ:WCRX)?
At the moment, there are a multitude of metrics market participants can use to monitor publicly traded companies.
Should You Buy Life Technologies Corp. (NASDAQ:LIFE)?
In today’s marketplace, there are many methods shareholders can use to analyze the equity markets. A duo of the most underrated are hedge fund and insider trading interest.
A Board Member Bought Over $300,000 of Abbott Labs
A member of Abbott Laboratories (NYSE:ABT)’s Board of Directors, William Osborn, recently bought 10,000 shares of stock at prices between $33.80 and $33.90.
Healthcare Investor Sam Isaly’s Top Stock Picks Include Pfizer
Sam Isaly’s Orbimed Advisors is a large health care fund investing in companies at various stages from venture capital to the public markets.
Billionaire Ken Fisher Thinks Pfizer Is Right For You
Billionaire Ken Fisher isn’t only the head of Fisher Asset Management, but also a long-running Forbes columnist whose picks published in that magazine have tended to outperform...
Orbimed Still Selling Pacira
Between April and June of this year, Orbimed Advisors sold 18% of its shares of Pacira Pharmaceuticals Inc (NASDAQ:PCRX), finishing the second quarter with exactly 2 million shares...
Why is Orbimed Backing Out of Amarin?
Orbimed Advisors, managed by Samuel Isaly, is a hedge fund with a focus on the healthcare sector.
Peter Kolchinsky’s RA Capital Management Raised Stake In Endocyte $ECYT
Peter Kolchinsky’s RA Capital Management reported 7.32% passive stake in Endocyte Inc. (ECYT).
Samuel Isaly Reported Changes in His Third Quarter Holdings
Samuel Isaly reported his amended 13F portfolio on November 23rd. He made a lot of changes to his original third quarter 13F which was filed a few days ago.
Insider Trading: Samuel Isaly’s Orbimed Advisors is Selling $ANTH
Samuel Isaly’s Orbimed Advisors filed for its recent insider sales in Anthera Pharmaceuticals Inc (ANTH) on November 18th.
Hedge Funds Make Big After Regeneron $REGN Gets FDA OK for Eylea
Regeneron Pharmaceuticals Inc.'s (REGN) shares rose 13.73% in trading on Monday after U.S.
Hedge Funds Make a Bundle on Inhibitex $INHX
Shares of Inhibitex (INHX) more than doubled Friday morning.
Hedge Funds Make Big on Humana $HUM
Humana Inc (HUM) swelled from $80.24 a share at open on Monday to hit anew 52-week high of $87.32 a share after it "announced earnings of $444.8 million, or $2.67 a share, up ...
Insider Trading: Daniel Gold’s QVT Financial Sold 650 Thousand Shares in $ANDS
Daniel Gold’s QVT Financial sold 650 thousand shares in Anadys Pharmaceuticals Inc. (ANDS) on October 17th. According to the firm’s Form 4 and amend 13D on October 19th.
Hedge Funds Make a Bundle on Edwards Lifesciences $EW Increase
Edwards Lifesciences Corp (EW) "third-quarter earnings rose 7.5% on a tax benefit as the heart-valve maker's investments in its expected Sapien launch hurt margins, despite sales...
